Real Diabetes Management Part 1: Making Our Data Speak to Us
{Note: this two-part series is aimed as much at Pharma as at patients. If you work in the industry, please read.}
If the emphasis among diabetes systems vendors last year at the annual American Diabetes Association Conference was “data visualization,” then this year’s was “data interpretation.“ I am 100% more enthused about the latter, and I’ll tell you why.
It seemed that last year, all the big players — J&J, Medtronic, Abbott Diabetes, Roche, and…